Navigation Links
Paired drugs kill precancerous colon polyps, spare normal tissue
Date:3/28/2010

HOUSTON - A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for chemoprevention of colon cancer, a team of scientists at The University of Texas M. D. Anderson Cancer Center reports in the advance online edition of the journal Nature.

The regimen, tested so far in mouse models and on human colon cancer tissue in the lab, appears to address a problem with chemopreventive drugs - they must be taken continuously long term to be effective, exposing patients to possible side effects, said senior author Xiangwei Wu, Ph.D., associate professor in M. D. Anderson's Department of Head and Neck Surgery.

"This combination can be given short term and periodically to provide a long-term effect, which would be a new approach to chemoprevention," Wu said.

The team found that a combination of Vitamin A acetate (RAc) and TRAIL, short for tumor necrosis factor-related apoptosis-inducing ligand, kills precancerous polyps and inhibits tumor growth in mice that have deficiencies in a tumor-suppressor gene. That gene, adenomatous polyposis coli (APC) and its downstream signaling molecules, are mutated or deficient in 80 percent of all human colon cancers, Wu said.

Ineffective separately, powerful together

Early experiments with APC-deficient mice showed that the two drugs combined or separately did not harm normal colon epithelial cells. Separately, they showed no effect on premalignant polyps called adenomas.

RAc and TRAIL together killed adenoma cells, causing programmed cell suicide know as apoptosis. RAc, researchers found, sensitizes polyp cells to TRAIL.

The scientists painstakingly tracked the molecular cascade caused by APC deficiencies, and found that insufficient APC sensitizes cells to TRAIL and RAc by suppressing a protein that blocks TRAIL.

Reductions in polyps, improved survival

APC-deficien
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Novelty lures rats from cocaine-paired settings, hinting at new treatments for recovering addicts
2. Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes
3. LaundryView(R) Makes Doing Laundry More Convenient for the Visually Impaired
4. Lighthouse International Introduces a New, Customizable, Low-Vision Simulator That Shows How the World Looks to People Who Are Visually Impaired
5. New Drugs, New Combinations Fight Breast Cancer
6. NICE guidelines ration affordable osteoporosis drugs
7. Bone Drugs May Beat Back Breast Cancer
8. Rehabilitation for Opiate Addiction Without Maintenance Drugs
9. Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
10. Fake Drugs Bought on the Web Pose Big Health Risks
11. Scientists show how molecular switch helps pancreatic cancer beat drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Paired drugs kill precancerous colon polyps, spare normal tissue
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
(Date:12/26/2014)... The US represents the largest market for CRC ... forecast estimates that sales of branded therapies were $2.23 billion. ... high incidence of the disease, high drug treatment rate, and ... Increased sales of CRC therapies over the forecast period will ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Challenge on First Day ... Illnesses, MINNEAPOLIS, June 5 Just one more hour ... mortality causing,illnesses including obesity, Type 2 diabetes, respiratory disorders and,high ... activities into your day, the sleep experts at Select Comfort(R),(Nasdaq: ...
... Indicator of Failures to Provide Basic Health Care,to Women, ... White,Ribbon Alliance for Safe Motherhood today made public its ... on Africa to invest in,women,s health as necessary to ... childbirth. "While we, too, see tremendous opportunity in,this, the ...
... SAN CARLOS, Calif., June 5 Nuvelo, Inc.,(Nasdaq: ... preclinical data from the,company,s Wnt Therapeutics program showing ... pathway, a signaling pathway that is critical for,cell ... proteins also amplified the activity of Wnt proteins, ...
... Charterhouse Group, Inc.,("Charterhouse") a New York-based ... supported growing middle-market companies since 1973,announced today ... and MTS Health Investors ("MTS") to complete ... ("CEA" or the "Company"), the,market leader in ...
... for Right To ... Red Ball Child Play Program, MORRIS PLAINS, N.J., June 5 ... makers of LISTERINE(R)* to help,Americans bring the benefits of healthy sports ... healthy routines,and physical activity, LISTERINE(R)* and the Hamm brothers are supporting,the ...
... Ticker Symbol: CUR, QUEBEC CITY, June 5 ... company commercializing high-value cancer diagnostic,tests and delivering laboratory ... second quarter 2008 financial results on June 13, ... be followed by a conference,call, which will be ...
Cached Medicine News:Health News:Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on 'Longest' Day of the Year 2Health News:Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on 'Longest' Day of the Year 3Health News:White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Women's Health 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 3Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 2Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 3Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 2Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 3Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 4Health News:DiagnoCure to host Q2 2008 earnings conference call and webcast 2
(Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
(Date:1/23/2015)... Jan. 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the development and sale of patented biopharmaceutical medicine, ... pharmaceutical ingredients (API) today announced the business and development ... 1. Following the September 2014 JCM application ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Watson Signs Agreement to Divest Equity Interest in ScinoPharm 2Watson Signs Agreement to Divest Equity Interest in ScinoPharm 3Watson Signs Agreement to Divest Equity Interest in ScinoPharm 4Watson Signs Agreement to Divest Equity Interest in ScinoPharm 5HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 2HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 3HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 4HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 5HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 6HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 7
37°C incubator for DianaGel cards....
Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
... different sized High-Throughput Submarine Systems are ... samples from microtitre plates. Analyze high ... synthetic oligos or PCR products simultaneously. ... for accuracy and speed with additional ...
... System™ (ID-MTS) Gel Test is ... of blood bank applications. Applications ... identification, ABO blood grouping and ... serum grouping and antigen typing, ...
Medicine Products: